North Central Cancer Treatment Group Phase II study of 5-fluorouracil and high-dose levamisole for gastric and gastroesophageal cancer using survival as the primary endpoint of efficacy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples